@phdthesis{Lorenzin2016,
  author    = {Lorenzin, Francesca},
  title     = {Regulation of transcription by MYC - DNA binding and target genes},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-150766},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2016},
  abstract  = {MYC is a transcription factor, whose expression is elevated or deregulated in many human cancers (up to 70\%) and is often associated with aggressive and poorly differentiated tumors. Although MYC is extensively studied, discrepancies have emerged about how this transcription factor works. In primary lymphocytes, MYC promotes transcriptional amplification of virtually all genes with an open promoter, whereas in tumor cells MYC regulates specific sets of genes that have significant prognostic value. Furthermore, the set of target genes that distinguish MYC's physiological function from the pathological/oncogenic one, whether it exists or not, has not been fully understood yet. In this study, it could be shown that MYC protein levels within a cell and promoter affinity (determined by E-box presence or interaction with other proteins) of target genes toward MYC are important factors that influence MYC activity. At low levels, MYC can amplify a certain transcriptional program, which includes high affinity binding sites, whereas at high levels MYC leads to the specific up- and down regulation of genes with low affinity. Moreover, the promoter affinity characterizes different sets of target genes which can be distinguished in the physiological or oncogenic MYC signatures. MYC-mediated repression requires higher MYC levels than activation and formation of a complex with MIZ1 is necessary for inhibiting expression of a subset of MYC target genes.},
  subject      = {MYC},
  language  = {en}
}